The Biden administration has taken on a worthy adversary with its "moonshot" goal of halving cancer deaths over the next 25 years and, in the process, saving 4 million lives. But what other "moonshot" projects would healthcare leaders take on?
Innovation
A survey of 2,014 adults from consulting giant Deloitte found that 53% believe generative artificial intelligence could improve access to healthcare.
General Catalyst's Head of the Health Assurance Ecosystem Daryl Tol said that despite the "very frustrating" healthcare industry, the investment firm is still going to "put a stake in the ground with healthcare systems," Yahoo Finance reported Nov. 14.
Trip Hofer, the former CEO of Optum Behavioral Health Solutions, joined healthcare venture capital firm .406 Ventures as a venture partner.
University of Miami Health System will implement AI from Aidoc to detect potential issues at the initial stages of care, streamline workflows and facilitate ongoing support throughout the post-diagnosis phase.
Software and IT companies Salesforce and Accenture are partnering to bring generative artificial intelligence tools to healthcare, life sciences and biopharma companies.
Fifty-one percent of U.S. adults expressed optimism about the potential for new applications of artificial intelligence to drive significant advancements and breakthroughs in healthcare in the coming year, a recent survey from Medtronic and Morning Consult found.
Two giants in their industries are joining forces.
Houston-based University of Texas MD Anderson Cancer Center has launched a huge data science project to advance oncology treatment, research and patient experience.
Nashville, Tenn.-based Vanderbilt University Medical Center and Durham, N.C. Duke University School of Medicine have received a $1.25 million grant from the Gordon and Betty Moore Foundation to enhance the supervision of AI technology within healthcare systems.